Established in 1984, the Duke Adult Bone Marrow and Stem Cell Transplantation (ABMT) Program has treated over 3,000 patients from all over the world over the past 20 years.

Many of those patients return to share their inspirational stories at the annual patient reunion each summer.

Promising Research

The ABMT team conducts extensive research not only into the potential of bone marrow and stem cell transplantation, but into the other kinds of treatments that can, in conjunction with transplantation, offer patients an even better prognosis. Some examples include immunotherapy, chemotherapy, and anti-angiogenesis therapy as well as other indications such as the use of these cells for peripheral vascular disease and acute myocardial infarction.

The program also offers a wide range of clinical trials, giving patients access to various new and experimental treatments.